Next Article in Journal
The Changing Face of Cystic Fibrosis and Its Implications for Screening
Previous Article in Journal
Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices
Previous Article in Special Issue
Considerations for Newborn Screening for Critical Congenital Heart Disease in Low- and Middle-Income Countries
Open AccessArticle

Pulse Oximetry and Congenital Heart Disease Screening: Results of the First Pilot Study in Morocco

1
Neonatal Intensive Care Unit, Mother and Child Hospital, Mohammed VI University Hospital, Marrakech 40000, Morocco
2
Laboratory Childhood, Health and Development, Marrakesh Medical School, Cadi Ayyad University, Marrakech 40000, Morocco
3
Children’s National Heart Institute, George Washington University School of Medicine, Washington, DC 20010, USA
4
Cardio-Vascular Surgery Center, Arazzi Hospital, Mohammed VI University Hospital, Marrakech 40000, Morocco
5
Pediatric Intensive Care, Mother and Child Hospital, Mohammed VI University Hospital, Marrakech 40000, Morocco
6
Gyneco-Obstetrical Unit, Mother and Child Hospital, Mohammed VI University Hospital, Marrakech 40000, Morocco
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2020, 6(3), 53; https://doi.org/10.3390/ijns6030053
Received: 18 May 2020 / Revised: 25 June 2020 / Accepted: 26 June 2020 / Published: 30 June 2020
Congenital heart disease (CHD) is the most common congenital malformation. Diagnosis of critical congenital heart disease (CCHD), the most severe type of congenital heart disease, in a newborn may be difficult. The addition of CCHD screening, using pulse oximetry, to clinical assessment significantly improves the rate of detection. We conducted a pilot study in Morocco on screening neonates for critical congenital heart disease. This study was conducted in the maternity ward of Mohammed VI University Hospital of Marrakesh, Morocco, and included asymptomatic newborns delivered between March 2019 and January 2020. The screening of CCHD was performed by pulse oximetry measuring the pre- and post-ductal saturation. Screening was performed on 8013/10,451 (76.7%) asymptomatic newborns. According to the algorithm, 7998 cases passed the screening test (99.82%), including one inconclusive test that was repeated an hour later and was normal. Fifteen newborns failed the screening test (0.18%): five CCHD, five false positives, and five CHD but non-critical. One false negative case was diagnosed at 2 months of age. Our results encourage us to strengthen screening for CCHD by adding pulse oximetry to the routine newborn screening panel. View Full-Text
Keywords: neonatal screening; congenital heart disease; pulse oximetry; telemedicine; Mohammed VI Hospital; Marrakesh; Morocco neonatal screening; congenital heart disease; pulse oximetry; telemedicine; Mohammed VI Hospital; Marrakesh; Morocco
Show Figures

Figure 1

MDPI and ACS Style

El Idrissi Slitine, N.; Bennaoui, F.; Sable, C.A.; Martin, G.R.; Hom, L.A.; Fadel, A.; Moussaoui, S.; Inajjarne, N.; Boumzebra, D.; Mouaffak, Y.; Younous, S.; Boukhanni, L.; Maoulainine, F.M.R. Pulse Oximetry and Congenital Heart Disease Screening: Results of the First Pilot Study in Morocco. Int. J. Neonatal Screen. 2020, 6, 53.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop